1. Home
  2. ADMA vs DX Comparison

ADMA vs DX Comparison

Compare ADMA & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

N/A

Current Price

$13.26

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Dynex Capital Inc.

DX

Dynex Capital Inc.

N/A

Current Price

$9.93

Market Cap

2.6B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ADMA
DX
Founded
2004
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
ADMA
DX
Price
$13.26
$9.93
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
★ $18.00
$12.60
AVG Volume (30 Days)
3.8M
★ 5.9M
Earning Date
11-04-2026
10-19-2026
Dividend Yield
N/A
★ 20.71%
EPS Growth
N/A
★ 65.77
EPS
★ 0.57
N/A
Revenue
★ $42,219,783.00
N/A
Revenue This Year
$4.49
$2.39
Revenue Next Year
$14.91
$41.18
P/E Ratio
$23.39
★ N/A
Revenue Growth
★ 43.85
N/A
52 Week Low
$7.21
$9.60
52 Week High
$20.46
$14.93

Technical Indicators

Market Signals
Indicator
ADMA
DX
Relative Strength Index (RSI) 61.74 34.28
Support Level $7.84 N/A
Resistance Level $13.77 $11.17
Average True Range (ATR) 0.74 0.30
MACD 0.02 -0.05
Stochastic Oscillator 74.43 19.59

Price Performance

Historical Comparison
ADMA
DX

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About DX Dynex Capital Inc.

Dynex Capital Inc is a real estate investment trust (REIT) focused on delivering dividends supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company is internally managed and mainly invests in residential and commercial mortgage-backed securities (RMBS and CMBS), which are Agency securities guaranteed by U.S. government-sponsored enterprises (GSEs). It manages interest rate, prepayment, spread, liquidity, and counterparty risks and operates through one reportable segment investing in MBS funded with repurchase agreements and equity.

Share on Social Networks: